Home : Unsafe Drugs : Serevent : Newsfeeds
Serevent - Newsfeeds
- Philadelphia Business Journal - Its line includes Advair, Flovent, Serevent, Valtrex, Paxil, Wellbutrin, Imitrex, Augmentin and more. The company has annual revenue of about $39.8 billion and employs about 100,000 people. In 2006, the company completed of its acquisition of ID ...
- Medical News Today - For asthma, individual LABAs such as GlaxoSmithKline's Serevent and Schering-Plough/Novartis's Foradil do not achieve so much as a 1.8% patient share until the third line, yet GlaxoSmithKline's Advair, a LABA/ICS combination, captures 13.9%, 19.3 ...
- Triangle Business Journal - Its line includes Advair, Flovent, Serevent, Valtrex, Paxil, Wellbutrin, Imitrex, Augmentin and more. The company has annual revenue of about $39.8 billion and employs about 100,000 people. In 2006, the company completed of its acquisition of ID ...
- WTNH.com - The long-acting bronchodilators include salmeterol (Serevent), metaproterenol (Alupent), and theophylline (Aerolate, Bronkodyl, Slo-phyllin, and Theo-Dur). Serevent and Alupent are inhaled and theophylline is taken orally. Advair combines ...
- Phramalive.com - Reisner played a diverse and integral role in the development of several key products including Advair(R) Diskus(R) and Serevent(R) Diskus(R) for COPD, Serevent(R) and Flovent(R) pediatric programs, Ventolin(R) HFA dose counter, and led the final ...
- KOLD-TV - The long-acting bronchodilators are salmeterol (Serevent), metaproterenol (Alupent), and theophylline (Aerolate, Bronkodyl, Slo-phyllin, and Theo-Dur to name a few). Serevent and Alupent are inhaled and theophylline is taken orally. These drugs are ...
- Medical News Today - Untreated and uncontrolled asthma is an urgent public health issue and Serevent® (salmeterol xinafoate) and Advair® (fluticasone propionate and salmeterol) when taken as indicated help children and adults with asthma control their symptoms. As ...
- CNBC - WASHINGTON - Government advisers recommended Wednesday that GlaxoSmithKline add more language about risks in children to its asthma drugs Serevent and Advair. The Food and Drug Administration said it would continue studying the safety of the ...
- MSN MoneyCentral - WASHINGTON (AP) - Government advisers recommended Wednesday that GlaxoSmithKline add more language about risks in children to its asthma drugs Serevent and Advair. The Food and Drug Administration said it would continue studying the safety of the ...
- HealthCentral.com - GAITHERSBURG, Md. (Reuters) - U.S. regulatory advisers on Wednesday recommended strengthening safety warnings on GlaxoSmithKline Plc's asthma drug Serevent amid new reports of deaths in children taking the drug. The U.S. Food and Drug Administration ...
- Triangle Business Journal - GSK laying off Triangle workers [Raleigh/Durham] FDA panel recommends flu-drug warning [Philadelphia] FDA warns GSK over Tykerb letters [Raleigh/Durham] GlaxoSmithKline 's best-selling drug Advair, manufactured in part at a plant in Zebulon, may get ...
- Wall Street Journal - A Food and Drug Administration advisory committee said the GlaxoSmithKline PLC asthma drugs Serevent and Advair should get new warning language in their labels focused on their potential risk for children. An official from the FDA, which typically ...
- Pharmaceutical Business Review - An FDA advisory committee has stated that GlaxoSmithKline's Serevent (salmeterol) and Advair (salmeterol/fluticasone) should get new warning language in their labels about their potential risk for children. The agency plans to conduct a review of the ...
- WebWire - Untreated and uncontrolled asthma is an urgent public health issue and Serevent® (salmeterol xinafoate) and Advair® (fluticasone propionate and salmeterol) when taken as indicated help children and adults with asthma control their symptoms. As ...
- WebMD - The two drugs, Serevent and Advair , already carry "black box" warnings that the active ingredient salmeterol may increase the risk of asthma -related death. But experts said Wednesday those warnings don't go far enough to caution that the drugs could ...
- Austin American-Statesman - TUESDAY, Nov. 27 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel on Wednesday urged that stronger label warnings focused on children be added to the packaging for Serevent and Advair, two widely used asthma drugs. Both drugs ...
- Reuters - GAITHERSBURG, Md., Nov 28 (Reuters) - U.S. regulatory advisers on Wednesday recommended strengthening safety warnings on GlaxoSmithKline Plc's (GSK.L: Quote , Profile , Research ) asthma drug, Serevent, following reports of several deaths in children ...
- CNBC - WASHINGTON - Government advisers on Wednesday will consider whether a GlaxoSmithKline asthma drug poses greater risks to children than to adults. The Food and Drug Administration has asked a panel of outside experts to review Glaxo's Serevent as part ...
- Reuters - WASHINGTON, Nov 28 (Reuters) - U.S. regulatory advisers on Wednesday are mulling whether to beef up warnings on GlaxoSmithKline's (GSK.L: Quote , Profile , Research ) asthma drug Serevent following reports of several deaths in patients taking the ...
- Bloomberg - Nov. 28 (Bloomberg) -- GlaxoSmithKline Plc's best-selling asthma drugs Advair and Serevent should carry stronger warnings about the risk of deadly side effects in children, a panel said. Outside advisers to the U.S. Food and Drug Administration voted ...
Looking for a Serevent attorney in Washington, DC? Get in touch with one of our Serevent attorneys in Washington, DC now.
Pages: 1 2 3 4 5 6 ... Next
